EP1786408A4 - Utilisation d'un modulateur selectif du recepteurs des oestrogenes dans la fabrication d'une preparation pharmaceutique utilisee dans une methode de traitement ou de prevention des insuffisances endrogeniques - Google Patents
Utilisation d'un modulateur selectif du recepteurs des oestrogenes dans la fabrication d'une preparation pharmaceutique utilisee dans une methode de traitement ou de prevention des insuffisances endrogeniquesInfo
- Publication number
- EP1786408A4 EP1786408A4 EP05771627A EP05771627A EP1786408A4 EP 1786408 A4 EP1786408 A4 EP 1786408A4 EP 05771627 A EP05771627 A EP 05771627A EP 05771627 A EP05771627 A EP 05771627A EP 1786408 A4 EP1786408 A4 EP 1786408A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- prevention
- manufacture
- treatment
- pharmaceutical preparation
- estrogen receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60690704P | 2004-09-03 | 2004-09-03 | |
FI20041216A FI20041216A0 (fi) | 2004-09-21 | 2004-09-21 | Menetelmä androgeenivajeen hoitoon tai estoon |
PCT/FI2005/000333 WO2006024689A1 (fr) | 2004-09-03 | 2005-07-20 | Utilisation d'un modulateur selectif du recepteurs des oestrogenes dans la fabrication d'une preparation pharmaceutique utilisee dans une methode de traitement ou de prevention des insuffisances endrogeniques |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1786408A1 EP1786408A1 (fr) | 2007-05-23 |
EP1786408A4 true EP1786408A4 (fr) | 2010-07-28 |
Family
ID=35999733
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP05771627A Withdrawn EP1786408A4 (fr) | 2004-09-03 | 2005-07-20 | Utilisation d'un modulateur selectif du recepteurs des oestrogenes dans la fabrication d'une preparation pharmaceutique utilisee dans une methode de traitement ou de prevention des insuffisances endrogeniques |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1786408A4 (fr) |
JP (1) | JP2008511615A (fr) |
KR (1) | KR20070059110A (fr) |
AU (1) | AU2005279178A1 (fr) |
BR (1) | BRPI0514701A (fr) |
CA (1) | CA2578852A1 (fr) |
MX (1) | MX2007002606A (fr) |
NO (1) | NO20071160L (fr) |
RU (1) | RU2007112114A (fr) |
WO (1) | WO2006024689A1 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101636372B (zh) | 2007-02-14 | 2013-03-27 | 霍尔莫斯医疗有限公司 | 有治疗价值的三苯基丁烯衍生物的制备方法 |
US20080312239A1 (en) * | 2007-06-13 | 2008-12-18 | Quatrx Pharmaceuticals Company | Methods for the treatment of erectile dysfunction using fispemifene |
CN102939287B (zh) | 2010-06-10 | 2016-01-27 | 塞拉根制药公司 | 雌激素受体调节剂及其用途 |
US9193714B2 (en) | 2011-12-14 | 2015-11-24 | Seragon Pharmaceuticals, Inc. | Fluorinated estrogen receptor modulators and uses thereof |
US9744177B2 (en) * | 2014-03-10 | 2017-08-29 | Endorecherche, Inc. | Treatment of male androgen deficiency symptoms or diseases with sex steroid precursor combined with SERM |
EP3240771B1 (fr) | 2014-12-29 | 2019-02-20 | OLON S.p.A. | Procédé de préparation d'ospémifène et de fispémifène |
WO2023175010A1 (fr) * | 2022-03-15 | 2023-09-21 | Centre D'etude Des Cellules Souches (Cecs) | Utilisation du bazedoxifene pour augmenter la survie musculaire |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001036360A1 (fr) * | 1999-11-16 | 2001-05-25 | Hormos Medical Corporation | Derives de triphenylalcene et leur utilisation comme modulateurs selectifs des recepteurs aux oestrogenes |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL120262A (en) * | 1996-02-28 | 2001-01-28 | Pfizer | Droloxifene and derivatives thereof for use in increasing serum testosterone levels |
US6632447B1 (en) * | 1998-05-07 | 2003-10-14 | The University Of Tennessee Research Corporation | Method for chemoprevention of prostate cancer |
CO5271697A1 (es) * | 2000-01-12 | 2003-04-30 | Pfizer Prod Inc | Composiciones y procedimientos para el tratamiento de afecciones que responden a un aumento de testosterona |
JP2003534375A (ja) * | 2000-05-26 | 2003-11-18 | フィッチ,ハリー | 選択性抗エストロゲン薬を用いた男性におけるアンドロゲン欠乏症の治療法 |
US7067557B2 (en) * | 2000-05-26 | 2006-06-27 | Harry Fisch | Methods of treating androgen deficiency in men using selective antiestrogens |
EP1666033B1 (fr) * | 2001-11-29 | 2008-12-31 | GTX, Inc. | Prevention et traitement de l'osteoporose induite par la privation d'androgene |
-
2005
- 2005-07-20 CA CA002578852A patent/CA2578852A1/fr not_active Abandoned
- 2005-07-20 EP EP05771627A patent/EP1786408A4/fr not_active Withdrawn
- 2005-07-20 AU AU2005279178A patent/AU2005279178A1/en not_active Abandoned
- 2005-07-20 KR KR1020077006922A patent/KR20070059110A/ko not_active Application Discontinuation
- 2005-07-20 JP JP2007529372A patent/JP2008511615A/ja not_active Abandoned
- 2005-07-20 WO PCT/FI2005/000333 patent/WO2006024689A1/fr active Application Filing
- 2005-07-20 BR BRPI0514701-8A patent/BRPI0514701A/pt not_active IP Right Cessation
- 2005-07-20 RU RU2007112114/15A patent/RU2007112114A/ru not_active Application Discontinuation
- 2005-07-20 MX MX2007002606A patent/MX2007002606A/es unknown
-
2007
- 2007-03-01 NO NO20071160A patent/NO20071160L/no not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001036360A1 (fr) * | 1999-11-16 | 2001-05-25 | Hormos Medical Corporation | Derives de triphenylalcene et leur utilisation comme modulateurs selectifs des recepteurs aux oestrogenes |
Non-Patent Citations (3)
Title |
---|
DUSCHEK ERIK J J ET AL: "Effects of raloxifene on gonadotrophins, sex hormones, bone turnover and lipids in healthy elderly men", EUROPEAN JOURNAL OF ENDOCRINOLOGY, vol. 150, no. 4, April 2004 (2004-04-01), pages 539 - 546, XP002586475, ISSN: 0804-4643 * |
See also references of WO2006024689A1 * |
STEINER MITCHELL S ET AL: "Phase IIA clinical trial to test the efficacy and safety of Toremifene in men with high-grade prostatic intraepithelial neoplasia.", CLINICAL PROSTATE CANCER JUN 2003 LNKD- PUBMED:15046680, vol. 2, no. 1, June 2003 (2003-06-01), pages 24 - 31, XP009134590, ISSN: 1540-0352 * |
Also Published As
Publication number | Publication date |
---|---|
MX2007002606A (es) | 2007-05-15 |
JP2008511615A (ja) | 2008-04-17 |
KR20070059110A (ko) | 2007-06-11 |
AU2005279178A1 (en) | 2006-03-09 |
EP1786408A1 (fr) | 2007-05-23 |
BRPI0514701A (pt) | 2008-06-24 |
CA2578852A1 (fr) | 2006-03-09 |
WO2006024689A1 (fr) | 2006-03-09 |
RU2007112114A (ru) | 2008-10-10 |
NO20071160L (no) | 2007-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1829518A4 (fr) | Melangeur a usage medical pour l'administration de medicaments | |
EP1781183A4 (fr) | Dispositifs et procédés pour l'ancrage pylorique | |
EP1962722A4 (fr) | Procedes et systemes pour le traitement de l'anevrisme utilisant des structures de remplissage | |
EP1830956A4 (fr) | Materiaux catalytiques et procede pour leur preparation | |
EP1733310A4 (fr) | Systeme et procede permettant de creer des ortheses | |
IL181043A0 (en) | Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof | |
IL180955A0 (en) | Progesterone receptor modulators comprising pyrrole- oxindole derivatives and uses thereof | |
GB0420016D0 (en) | Controlled release oral delivery system | |
HK1130234A1 (en) | Closure device providing visual confirmation of occlusion | |
IL209402A (en) | A process for making opioid receptor regulators and opioid receptor regulators made by him | |
EP1786408A4 (fr) | Utilisation d'un modulateur selectif du recepteurs des oestrogenes dans la fabrication d'une preparation pharmaceutique utilisee dans une methode de traitement ou de prevention des insuffisances endrogeniques | |
SI1786744T1 (sl) | Postopek za zaviranje vezave mavca in pripravkov iz mavca | |
IL182287A0 (en) | A method of contraception utilizing hormonal treatment | |
ZA200700483B (en) | Process for the preparation 2-substituted-derivatives of estrone and estradiol | |
EP2063881A4 (fr) | Composition et méthode pour administrer efficacement et sans danger un halopyruvate pour traiter un cancer | |
EP2138168A4 (fr) | Agent destiné à l'administration par voie orale et son procédé de production | |
EP1753405A4 (fr) | Preparation pharmaceutique a liberation lente | |
EP1809266A4 (fr) | Composes et methodes anticancereux | |
ZA200702038B (en) | Pharmaceutical composition drospirenone and ethynyle-stradiol | |
EP1765373A4 (fr) | Composition pharmaceutique ozonisee et procede associe | |
HK1102395A1 (en) | Indene derivatives and process for the preparation thereof | |
IL181819A (en) | Use of Benzo-compound compounds for the preparation of pharmaceuticals and the uses of these @ compounds | |
EP1726313A4 (fr) | Medicament pour la prevention et le traitement de l'arteriosclerose | |
IL183702A0 (en) | Difluoronucleosides and process for preparation thereof | |
EP1756036A4 (fr) | Derives indenes et leur procede d'elaboration |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20070306 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
DAX | Request for extension of the european patent (deleted) | ||
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: KOMI, JANNE Inventor name: BLOM, TARU Inventor name: LAMMINTAUSTA, RISTO |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 31/085 20060101AFI20100615BHEP Ipc: A61K 31/10 20060101ALI20100615BHEP Ipc: A61P 5/32 20060101ALI20100615BHEP Ipc: A61K 31/135 20060101ALI20100615BHEP Ipc: A61K 31/395 20060101ALI20100615BHEP Ipc: A61K 31/4164 20060101ALI20100615BHEP Ipc: A61P 5/26 20060101ALI20100615BHEP |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20100628 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20110126 |